Document Detail

Prenatal therapy for fetal growth restriction.
MedLine Citation:
PMID:  16721109     Owner:  NLM     Status:  MEDLINE    
The choice of therapy for fetal growth restriction (FGR) depends on the nature of the insult that led to the development of FGR. Many etiologic factors are either not amenable to therapy or fetal growth has not been improved by treatments that benefit the mother. Many therapeutic approaches have been used to improve fetal condition. None of the approaches have been of value in a consistent manner. We present the numerous approaches, and their rationale for their use, that have been tried to treat the growth impaired fetus. The evidence from the randomized clinical trials is summarized and their conclusions given.
Reinaldo Figueroa; Dev Maulik
Related Documents :
20004469 - Review: sex and the human placenta: mediating differential strategies of fetal growth a...
3892389 - Intrauterine growth in twin pregnancies: prediction of fetal growth retardation.
8621339 - Computer-assisted stereological analysis of gastric volume during the human embryonic p...
14519479 - Fetal growth restriction and consequences for the offspring in animal models.
24382949 - Early pregnancy diagnosis in bovines: current status and future directions.
11536139 - Microbial growth by a net heat up-take: a calorimetric and thermodynamic study on aceto...
15121629 - Management of eisenmenger syndrome in pregnancy with sildenafil and l-arginine.
16597079 - Prenatal, perinatal, and heritable influences on cord blood immune responses.
20630069 - The impact of temporal variability of biochemical markers papp-a and free beta-hcg on t...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Clinical obstetrics and gynecology     Volume:  49     ISSN:  0009-9201     ISO Abbreviation:  Clin Obstet Gynecol     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-05-24     Completed Date:  2008-01-16     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0070014     Medline TA:  Clin Obstet Gynecol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  308-19     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Winthrop University Hospital, Mineola, New York, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adrenergic beta-Agonists / administration & dosage
Aspirin / administration & dosage
Bed Rest
Calcium Channel Blockers / administration & dosage
Calcium, Dietary / administration & dosage
Diet, Sodium-Restricted
Dietary Supplements
Fetal Growth Retardation / drug therapy,  prevention & control,  therapy*
Fish Oils / administration & dosage
Folic Acid / administration & dosage
Iron Compounds / administration & dosage
Lower Body Negative Pressure
Magnesium Compounds / administration & dosage
Meta-Analysis as Topic
Nitric Oxide Donors / administration & dosage
Nutritional Support
Oxygen Inhalation Therapy
Plasma Substitutes / administration & dosage
Pregnancy Outcome
Randomized Controlled Trials as Topic
Vitamins / administration & dosage
Zinc Compounds / administration & dosage
Reg. No./Substance:
0/Adrenergic beta-Agonists; 0/Calcium Channel Blockers; 0/Calcium, Dietary; 0/Fish Oils; 0/Iron Compounds; 0/Magnesium Compounds; 0/Nitric Oxide Donors; 0/Plasma Substitutes; 0/Vitamins; 0/Zinc Compounds; 50-78-2/Aspirin; 59-30-3/Folic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Sonographic diagnosis of fetal growth restriction.
Next Document:  Management of fetal growth restriction: an evidence-based approach.